SEC Filing Details

Investors

Document Details

Form
424B5
Filing Date
February 7, 2024
Document Date
February 7, 2024
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Jasper Therapeutics, Inc
Issuer
JASPER THERAPEUTICS, INC.
Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.

 

Continue
Cancel